COMMUNIQUÉS West-GlobeNewswire

iKang Schedules 2017 Unaudited Second Quarter Earnings Release on December 14, 2017
28/11/2017
BEIJING, Nov. 28, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Teladoc Announces Proposed Sale of Shares of Common Stock
28/11/2017
PURCHASE, NY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced a proposed offering of shares of its common stock, which includes 3,250,000 shares offered by Teladoc and 830,000 [...]
Flexion Therapeutics to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
28/11/2017
BURLINGTON, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President [...]
Cytori Closes Rights Offering for Gross Proceeds of $10 Million
28/11/2017
SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc . (“Cytori”) (NASDAQ: CYTX ) announced today the closing of its rights offering (the “Rights Offering”) to subscribe for units at a subscription [...]
Iovance Biotherapeutics to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
28/11/2017
SAN CARLOS, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Ovid Therapeutics Announces OV101 Shows Comparable PK Profile in Phase 1 Study of Adolescent Patients and Amends Phase 2 STARS Clinical Trial Protocol to Include Adolescents
28/11/2017
-- Results from the Phase 1 Clinical Trial of Adolescents with Angelman and Fragile X Syndromes Demonstrated OV101 was Well Tolerated with a Pharmacokinetic Profile Similar to Adults -- -- With Core Expertise in [...]
Emblem Announces Third Quarter 2017 Financial Results
28/11/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically [...]
eRAD RIS Selected by Drs Schnetler, Corbett and Partners Radiology
28/11/2017
GREENVILLE, S.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- eRAD announced today that Drs Schnetler, Corbett and Partners Radiology (SCP Radiology) has selected eRAD’s Radiology Information System (RIS) to manage its clinical [...]
Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design
28/11/2017
SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. The company raised [...]
Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer
28/11/2017
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to “ [...]
Irvine Facial Plastic Surgeon Distinguishes Between Lip Enhancement Options
28/11/2017
IRVINE, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- As people age, the lips become susceptible to volume loss. The lips may gradually appear thin or begin to lose their definition. In response to this common cosmetic [...]
PDC Healthcare Launches New DuraProtect™ Laser Wristbands Engineered to Deliver Greater Durability at a Lower Cost
28/11/2017
VALENCIA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PDC Healthcare , a global leader of innovative identification and patient safety solutions, announced today the launch of DuraProtect ™, its newest line of laser [...]
Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement
28/11/2017
EAGAN, Minn., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that it has entered into a clinical trial collaboration agreement with Genentech, Inc., a member of the Roche Group, to [...]
Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care DPP® Zika Assays and DPP® Micro Readers
28/11/2017
MEDFORD, N.Y., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has been awarded a [...]
ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting
28/11/2017
SEOUL, South Korea, Nov. 28, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR technology at the upcoming [...]
CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic
28/11/2017
Goal is a safer, more effective version of Yervoy ® Triggers $10 Million Milestone Payment to CytomX from Bristol Myers Squibb NEW YORK and SOUTH SAN FRANCISCO, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- CytomX [...]
Cidara Therapeutics Completes Enrollment in Phase 2 STRIVE Trial Evaluating Novel Antifungal Rezafungin (CD101 IV) in Invasive Fungal Infections
28/11/2017
SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the completion of patient [...]
Catalyst Biosciences Strengthens Clinical Hemophilia Programs with Additions to its Senior Leadership Team
28/11/2017
-- Appoints Arwa Shurrab as Vice President of Regulatory Affairs and Jamie Ellen Siegel, M.D., as Head of Clinical Development -- SOUTH SAN FRANCISCO, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc [...]
Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma
28/11/2017
MINNEAPOLIS, Nov. 28, 2017 (GLOBE NEWSWIRE) -- GLG Pharma, a Jupiter, Florida company developing precision medicines that target the Signal Transducer and Activator of Transcription factor 3 (“p-STAT3 and STAT3”) [...]

Pages